DEF 14A: Intuitive Surgical Seeks Stockholder Approval for Amended Incentive and Stock Purchase Plans
Definitive Proxy Statement
Intuitive Surgical is asking stockholders to approve amendments to its incentive award plan and employee stock purchase plan at the 2024 annual meeting.
Summary
- Intuitive Surgical is seeking stockholder approval for several proposals at its 2024 Annual Meeting, including the election of eleven directors, advisory approval of executive compensation, ratification of the appointment of PricewaterhouseCoopers LLP as the independent accounting firm, and approval of amendments to the 2010 Incentive Award Plan and the 2000 Employee Stock Purchase Plan.
- The company is requesting an increase of 5,000,000 shares to the 2010 Incentive Award Plan, bringing the total to 115,350,000 shares, extending the plan's term to March 6, 2034, including minimum award vesting limitations, specifying the treatment of awards in connection with a change in control, and revising certain provisions regarding tax withholding.
- They are also seeking an increase of 4,000,000 shares to the 2000 Employee Stock Purchase Plan, bringing the total to 26,770,945 shares, to provide employees with the opportunity to purchase company stock through payroll deductions.
- The Board recommends voting for the election of directors, the advisory approval of executive compensation, the ratification of the accounting firm, and the approval of the plan amendments, but against the stockholder proposal requesting a racial and gender pay gap report.
Sentiment
Score: 7
Explanation: The document is primarily informational, outlining proposals for stockholder voting. The tone is professional and forward-looking, with an emphasis on aligning employee and stockholder interests. The Board's recommendations are clearly stated, and the document provides detailed information on compensation practices and corporate governance.
Positives
- The proposed amendments to the incentive award plan are intended to align employee interests with those of stockholders and attract and retain talent.
- The proposed increase in shares for the employee stock purchase plan aims to provide employees with the opportunity to purchase company stock and align their interests with the company's success.
- The company already has strong programs, practices, and oversight and its robust disclosure concerning pay equity.
Negatives
- The Board recommends voting against a stockholder proposal requesting a racial and gender pay gap report.
Risks
- If the Amended 2010 Plan is not approved, the Company may need to increase the cash component of employee compensation.
- The proposed unadjusted global and/or country-by-country median pay gap metric, as requested in the proposal, does not reflect how our Company measures and monitors our progress in advancing women and people of color and increasing their representation in leadership roles within our Company.
Future Outlook
The company anticipates that the requested shares under the Amended 2010 Plan, plus shares available under the 2010 Plan prior to the amendment, will enable them to fund their equity compensation program through the date of the 2025 Annual Meeting of Stockholders.
Management Comments
- Gary S. Guthart, Ph.D., Chief Executive Officer: 'On behalf of our Board of Directors, thank you for your participation in this important annual process.'
Industry Context
The company competes with other technology and medical device companies for talent, particularly in Silicon Valley, making equity compensation a crucial tool for attracting and retaining employees.
Comparison to Industry Standards
- The company benchmarks its executive compensation against a peer group of companies in the technology, medical device, and life sciences industries, including Adobe, DexCom, Edwards Lifesciences, and Stryker.
- The company targets total direct compensation values between the 50th and 75th percentiles of its peers.
Stakeholder Impact
- Approval of the proposals is expected to benefit stockholders by aligning employee incentives with long-term value creation.
- Employees will benefit from the opportunity to purchase company stock and participate in the company's success.
- The company's ability to attract and retain talent will be enhanced by the proposed changes to the incentive award plan.
Next Steps
- Stockholders will vote on the proposals at the Annual Meeting on April 25, 2024.
- The company will continue to monitor and adjust its compensation practices to remain competitive and aligned with stockholder interests.
Key Dates
| Date | Description |
|---|---|
| 2000 | Initial adoption of the 2000 Employee Stock Purchase Plan |
| 2010 | Initial approval of the 2010 Incentive Award Plan |
| February 2, 2017 | Previous amendment and restatement of the 2000 Employee Stock Purchase Plan |
| April 20, 2017 | Stockholder approval of the previous amendment and restatement of the 2000 Employee Stock Purchase Plan |
| February 29, 2024 | Record date for the 2024 Annual Meeting of Stockholders |
| March 6, 2024 | Date of Board approval for the amendment and restatement of the 2010 Incentive Award Plan |
| March 6, 2024 | Date of Board approval for the amendment and restatement of the 2000 Employee Stock Purchase Plan |
| March 8, 2024 | Date of Proxy Statement |
| March 12, 2024 | Approximate date on which the Notice will be mailed to stockholders |
| April 25, 2024 | Date of the 2024 Annual Meeting of Stockholders |
| November 12, 2024 | Deadline for receipt of stockholder proposals for the 2025 Annual Meeting of Stockholders |
| December 26, 2024 | Earliest date for receipt of stockholder nominations for director or to propose business at the 2025 Annual Meeting of Stockholders |
| January 25, 2025 | Latest date for receipt of stockholder nominations for director or to propose business at the 2025 Annual Meeting of Stockholders |
| February 24, 2025 | Latest date for stockholders to provide notice of intent to solicit proxies in support of director nominees other than the company's nominees for the 2025 Annual Meeting of Stockholders |
| April 25, 2025 | Date of the 2025 Annual Meeting of Stockholders |
| March 6, 2034 | Extended term of the Amended 2010 Plan |
Keywords
incentive award plan, employee stock purchase plan, executive compensation, board of directors, proxy statement, stockholders, corporate governance, equity, compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.